Operating Lease, Right-of-Use Asset of BioNexus Gene Lab Corp from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BioNexus Gene Lab Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • BioNexus Gene Lab Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $186,082, a 20% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BioNexus Gene Lab Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $186,082 -$46,665 -20% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $200,284 -$41,416 -17% 30 Jun 2025 10-Q 18 Aug 2025 2025 Q2
Q1 2025 $203,923 +$75,747 +59% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $215,243 +$73,699 +52% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $232,747 +$91,203 +64% 30 Sep 2024 10-Q 15 Nov 2024 2024 Q3
Q2 2024 $241,700 +$196,804 +438% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $128,176 +$76,740 +149% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $141,544 +$85,814 +154% 31 Dec 2023 10-Q 14 Nov 2025 2025 Q3
Q3 2023 $141,544 +$116,569 +467% 30 Sep 2023 10-Q 15 Nov 2024 2024 Q3
Q2 2023 $44,896 +$14,391 +47% 30 Jun 2023 10-Q 16 Aug 2023 2023 Q2
Q1 2023 $51,436 +$15,075 +41% 31 Mar 2023 10-Q 16 Aug 2023 2023 Q2
Q4 2022 $55,730 +$14,640 +36% 31 Dec 2022 10-K 15 Apr 2025 2024 FY
Q3 2022 $24,975 -$19,640 -44% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $30,505 -$20,760 -40% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $36,361 -$19,386 -35% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $41,090 -$21,439 -34% 31 Dec 2021 10-K 16 Apr 2024 2023 FY
Q3 2021 $44,615 +$30,357 +213% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $51,265 +$34,620 +208% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $55,747 +$36,151 +184% 31 Mar 2021 10-Q 18 May 2021 2021 Q1
Q4 2020 $62,529 +$38,987 +166% 31 Dec 2020 10-K 06 Apr 2022 2021 FY
Q3 2020 $14,258 30 Sep 2020 10-Q/A 09 Nov 2020 2020 Q3
Q2 2020 $16,645 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $19,596 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $23,542 31 Dec 2019 10-K 30 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.